Key takeaways: Glucagon-like peptide-1 (GLP-1) medications like semaglutide (Wegovy, Ozempic, Rybelsus) and tirzepatide (Zepbound, Mounjaro) aren't interchangeable
Introduction The landscape of weight management has been significantly transformed by the advent of GLP-1 receptor agonists, a class of medications that have shown remarkable efficacy in supporting sustainable weight loss and improving metabolic health
Dexamethasone in hospitalized patients with Covid-19 preliminary report
The researchers assessed the change in body weight from baseline within each trial and subgroup and they also carried out a mediation analysis to differentiate between direct and indirect effects of semaglutide on weight loss, the latter of which was mediated by nausea or vomiting
The secondary renal outcome was a composite of the following components: new-onset persistent macroalbuminuria, persistent doubling of the serum creatinine level, ESRD, or death due to renal disease
As of the time of writing, retatrutide has not received approval from the MHRA or EMA, and its full safety profile remains under investigation